Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Cryopreserved Fibroblast and Mesenchymal Stem Cells (MSCs) Being Alternative Mitochondrial Donors for Mitochondrial Organelle Transplantation (MOT)

October 2024 Bioprinting, Bioprocessing, Cardiovascular, MedTech, Devices, & Materials, Tissue Engineering

The ARDS microenvironment enhances MSC-induced repair via VEGF in experimental acute lung inflammation

October 2024 Bioprocessing, Cancer, Cardiovascular, Cell Therapy, Clinical, Immunomodulation, Lung

Endothelial cells increase mesenchymal stem cell differentiation in scaffold-free 3D vascular tissue

September 2024 Bioprinting, Cardiovascular, Tissue Engineering

Functional high capacity exosome-encapsulating bioinspired hydrogel promotes microvascular bed expansion in diabetic mice

August 2024 Bioprinting, Bioprocessing, Cardiovascular, Cell Therapy, Clinical, Dermal and Wound, Diabetes, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

Mesenchymal Stem Cell-Conditioned Media-Loaded Microparticles Enhance Acute Patency in Silk-Based Vascular Grafts

August 2024 Bioprinting, Bioprocessing, Cardiovascular, Immunomodulation, MedTech, Devices, & Materials, Tissue Engineering

Vascularization of Bioengineered Fat With Tunable Matrix Properties for Macro-Perfusion and Soft Tissue Reconstruction

August 2024 Bioprinting, Cardiovascular, MedTech, Devices, & Materials, Tissue Engineering

GMP-compliant iPS cell lines show widespread plasticity in a new set of differentiation workflows for cell replacement and cancer immunotherapy

July 2024 Bioprocessing, Blood, Cancer, Cardiovascular, Immunomodulation, Tissue Engineering

Role of Adipose-Derived Mesenchymal Stem Cells in Bone Regeneration

June 2024 Bioprinting, Cardiovascular, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Orthopedic, Tissue Engineering

BLOOD-COMPATIBLE ENDOMETRIAL MESENCHYMAL STEM CELLS FOR CLINICAL APPLICATION

June 2024 Bioprinting, Bioprocessing, Blood, Cardiovascular, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Gene Editing, Immunomodulation, Tissue Engineering

Biological differences between adult and perinatal human mesenchymal stromal cells and their impact on the manufacturing processes

May 2024 Bioprinting, Cardiovascular, Cell Therapy, Clinical, Immunomodulation, Orthopedic, Tissue Engineering
Previous 1 2 3 4 5 6 7 8 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email